| Name | Title | Contact Details |
|---|---|---|
Rebecca Milbury |
Chief People Officer | Profile |
Lara Steele |
Director of Employee Experience | Profile |
Julie Burek |
Vice President, Financial Planning and Analysis | Profile |
Richard Whitaker |
Associate Director, People Operations | Profile |
Mike Palladino |
Senior Vice President, Legal, Human Resources and Corporate Communications | Profile |
Pleiad is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Citizens Choice Healthplan is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kansas Health Solutions is a Topeka, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Tegria, we believe that the right technology and tools can help make care more effective for more people. Launched in 2020 with support from Providence, one of the country`s largest health systems, Tegria combines innovative technologies and services to create powerful solutions that simplify healthcare for everyone involved. We built Tegria to make a difference, not only for our customers, but for our communities. We deliver complete solutions to streamline the process of receiving and delivering care, from first visit to follow-up and beyond.